Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition

Umesh C S Yadav, Satish Srivastava, Kota Ramana

Research output: Contribution to journalArticle

20 Citations (Scopus)

Abstract

Objective: Since diabetes-induced vascular endothelial growth factor (VEGF) is implicated in retinal angiogenesis, we aimed to examine the role of aldose reductase (AR) in VEGF-induced human retinal endothelial cells (HREC) growth and tube formation. Materials and Methods: HRECs were stimulated with VEGF and cell-growth was determined by MTT assay. AR inhibitor, fidarestat, to block the enzyme activity and AR siRNA to ablate AR gene expression in HREC were used to investigate the role of AR in neovascularization using cell-migration and tube formation assays. Various signaling intermediates and angiogenesis markers were assessed by Western blot analysis. Immuno-histochemical analysis of diabetic rat eyes was performed to examine VEGF expression in the retinal layer. Results: Stimulation of primary HREC with VEGF caused increased cell growth and migration, and AR inhibition with fidarestat or ablation with siRNA significantly prevented it. VEGF-induced tube formation in HREC was also significantly prevented by fidarestat. Treatment of HREC with VEGF also increased the expression of VCAM, AR, and phosphorylation and activation of Akt and p38-MAP kinase, which were prevented by fidarestat. VEGF-induced expression of VEGFRII in HREC was also prevented by AR inhibition or ablation. Conclusions: Our results indicate that inhibition of AR in HREC prevents tube formation by inhibiting the VEGF-induced activation of the Akt and p38-MAPK pathway and suggest a mediatory role of AR in ocular neovascularization generally implicated in retinopathy and AMD.

Original languageEnglish (US)
Pages (from-to)369-377
Number of pages9
JournalJournal of Diabetes and its Complications
Volume26
Issue number5
DOIs
StatePublished - Sep 2012

Fingerprint

Aldehyde Reductase
Vascular Endothelial Growth Factor A
Endothelial Cells
Growth
p38 Mitogen-Activated Protein Kinases
Small Interfering RNA
Cell Movement
Western Blotting
Phosphorylation
Gene Expression

Keywords

  • Aldose reductase
  • Neovascularization
  • Oxidative stress
  • Tube-formation
  • VEGF

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Internal Medicine

Cite this

Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition. / Yadav, Umesh C S; Srivastava, Satish; Ramana, Kota.

In: Journal of Diabetes and its Complications, Vol. 26, No. 5, 09.2012, p. 369-377.

Research output: Contribution to journalArticle

@article{12c3ae9a9a68481597a6321ed03ba8cb,
title = "Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition",
abstract = "Objective: Since diabetes-induced vascular endothelial growth factor (VEGF) is implicated in retinal angiogenesis, we aimed to examine the role of aldose reductase (AR) in VEGF-induced human retinal endothelial cells (HREC) growth and tube formation. Materials and Methods: HRECs were stimulated with VEGF and cell-growth was determined by MTT assay. AR inhibitor, fidarestat, to block the enzyme activity and AR siRNA to ablate AR gene expression in HREC were used to investigate the role of AR in neovascularization using cell-migration and tube formation assays. Various signaling intermediates and angiogenesis markers were assessed by Western blot analysis. Immuno-histochemical analysis of diabetic rat eyes was performed to examine VEGF expression in the retinal layer. Results: Stimulation of primary HREC with VEGF caused increased cell growth and migration, and AR inhibition with fidarestat or ablation with siRNA significantly prevented it. VEGF-induced tube formation in HREC was also significantly prevented by fidarestat. Treatment of HREC with VEGF also increased the expression of VCAM, AR, and phosphorylation and activation of Akt and p38-MAP kinase, which were prevented by fidarestat. VEGF-induced expression of VEGFRII in HREC was also prevented by AR inhibition or ablation. Conclusions: Our results indicate that inhibition of AR in HREC prevents tube formation by inhibiting the VEGF-induced activation of the Akt and p38-MAPK pathway and suggest a mediatory role of AR in ocular neovascularization generally implicated in retinopathy and AMD.",
keywords = "Aldose reductase, Neovascularization, Oxidative stress, Tube-formation, VEGF",
author = "Yadav, {Umesh C S} and Satish Srivastava and Kota Ramana",
year = "2012",
month = "9",
doi = "10.1016/j.jdiacomp.2012.04.017",
language = "English (US)",
volume = "26",
pages = "369--377",
journal = "Journal of Diabetes and its Complications",
issn = "1056-8727",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Prevention of VEGF-induced growth and tube formation in human retinal endothelial cells by aldose reductase inhibition

AU - Yadav, Umesh C S

AU - Srivastava, Satish

AU - Ramana, Kota

PY - 2012/9

Y1 - 2012/9

N2 - Objective: Since diabetes-induced vascular endothelial growth factor (VEGF) is implicated in retinal angiogenesis, we aimed to examine the role of aldose reductase (AR) in VEGF-induced human retinal endothelial cells (HREC) growth and tube formation. Materials and Methods: HRECs were stimulated with VEGF and cell-growth was determined by MTT assay. AR inhibitor, fidarestat, to block the enzyme activity and AR siRNA to ablate AR gene expression in HREC were used to investigate the role of AR in neovascularization using cell-migration and tube formation assays. Various signaling intermediates and angiogenesis markers were assessed by Western blot analysis. Immuno-histochemical analysis of diabetic rat eyes was performed to examine VEGF expression in the retinal layer. Results: Stimulation of primary HREC with VEGF caused increased cell growth and migration, and AR inhibition with fidarestat or ablation with siRNA significantly prevented it. VEGF-induced tube formation in HREC was also significantly prevented by fidarestat. Treatment of HREC with VEGF also increased the expression of VCAM, AR, and phosphorylation and activation of Akt and p38-MAP kinase, which were prevented by fidarestat. VEGF-induced expression of VEGFRII in HREC was also prevented by AR inhibition or ablation. Conclusions: Our results indicate that inhibition of AR in HREC prevents tube formation by inhibiting the VEGF-induced activation of the Akt and p38-MAPK pathway and suggest a mediatory role of AR in ocular neovascularization generally implicated in retinopathy and AMD.

AB - Objective: Since diabetes-induced vascular endothelial growth factor (VEGF) is implicated in retinal angiogenesis, we aimed to examine the role of aldose reductase (AR) in VEGF-induced human retinal endothelial cells (HREC) growth and tube formation. Materials and Methods: HRECs were stimulated with VEGF and cell-growth was determined by MTT assay. AR inhibitor, fidarestat, to block the enzyme activity and AR siRNA to ablate AR gene expression in HREC were used to investigate the role of AR in neovascularization using cell-migration and tube formation assays. Various signaling intermediates and angiogenesis markers were assessed by Western blot analysis. Immuno-histochemical analysis of diabetic rat eyes was performed to examine VEGF expression in the retinal layer. Results: Stimulation of primary HREC with VEGF caused increased cell growth and migration, and AR inhibition with fidarestat or ablation with siRNA significantly prevented it. VEGF-induced tube formation in HREC was also significantly prevented by fidarestat. Treatment of HREC with VEGF also increased the expression of VCAM, AR, and phosphorylation and activation of Akt and p38-MAP kinase, which were prevented by fidarestat. VEGF-induced expression of VEGFRII in HREC was also prevented by AR inhibition or ablation. Conclusions: Our results indicate that inhibition of AR in HREC prevents tube formation by inhibiting the VEGF-induced activation of the Akt and p38-MAPK pathway and suggest a mediatory role of AR in ocular neovascularization generally implicated in retinopathy and AMD.

KW - Aldose reductase

KW - Neovascularization

KW - Oxidative stress

KW - Tube-formation

KW - VEGF

UR - http://www.scopus.com/inward/record.url?scp=84865861778&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84865861778&partnerID=8YFLogxK

U2 - 10.1016/j.jdiacomp.2012.04.017

DO - 10.1016/j.jdiacomp.2012.04.017

M3 - Article

C2 - 22658411

AN - SCOPUS:84865861778

VL - 26

SP - 369

EP - 377

JO - Journal of Diabetes and its Complications

JF - Journal of Diabetes and its Complications

SN - 1056-8727

IS - 5

ER -